Krakow, Poland – 17 April 2019 – Selvita today announced that an abstract providing details of the Phase 1/2 study of SEL24/MEN1703 has been accepted as a poster presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place from May 31 to June 4, 2019, in Chicago….
Selvita to exhibit at the 14th Annual Drug Discovery Chemistry conference
Krakow, Poland – 4 April 2019 – Selvita, drug discovery and development partner for the pharmaceutical and biotechnology industries, will exhibit at the upcoming 14th Annual Drug Discovery Chemistry conference, taking place 8-12 April at the San Diego Convention Center, in San Diego, US. Throughout the whole event, Selvita’s…
Selvita to present at the 2019 HCW Global Life Sciences Conference in London
Krakow, Poland – 4 April 2019 – Selvita (WSE:SLV), a clinical stage company engaged in the research and development of novel cancer therapies, as well as provision of drug discovery and development services, will present at the upcoming 2019 HCW Global Life Sciences Conference, taking place on April 8-9 in…
Selvita to Separate Oncology Therapeutics and Contract Research Business Units into Two Global Companies
Two publicly traded companies to offer distinct opportunities for investment and growth Krakow, Poland – 28 March 2019 – Selvita (WSE:SLV), a clinical stage company engaged in the research and development of novel cancer therapies as well as provision of drug discovery and development services, today announced that it…
Selvita Posts 67 Percent Increase in Operating Profit for Services Division; Innovative Research Division Reaches Inflection Point as SEL120 Enters…
Krakow, Poland – 28 March 2019 – Selvita (WSE:SLV), a clinical stage company engaged in the research and development of novel cancer therapies as well as provision of drug discovery and development services, today announced that it has recognized dynamic growth last year in the Services Division. The segment’s revenues…
Selvita introduces new technologies and expands the range of services through PLN 14M infrastructure investments in 2018
Krakow, Poland – 27 March 2019 – Selvita, one of the largest providers of drug discovery services in Europe, announced the summary of the progression of its infrastructure development strategy initiated in 2017 which aimed at expansion of the range of capabilities offered by the Services Segment by introducing new…